Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JinCheng Guo

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Circulation|February 26, 2024
Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind TrialYan Yan, Jincheng Guo, Xiao Wang, et al.
Nucleic Acids Research|November 4, 2025
CCCdb: a comprehensive manually curated database for cell-cell communication in human and mouseMingcong Xu, Guorui Zhang, Xuan Wang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 26, 2021
Plaque characteristics in patients with ST-segment elevation myocardial infarction and early spontaneous reperfusionJincheng Guo, Jun Chen, Guozhong Wang, et al.
Current Medical Research and Opinion|March 19, 2019
China STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive patients: a one-year registry (China STATUS III)Yong Huo, Ye Gu, Genshan Ma, et al.
Nucleic Acids Research|October 31, 2021
TcoFBase: a comprehensive database for decoding the regulatory transcription co-factors in human and mouseYuexin Zhang, Chao Song, Yimeng Zhang, et al.
JAMA|March 17, 2015
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trialYaling Han, Jincheng Guo, Yang Zheng, et al.
Signal Transduction and Targeted Therapy|February 24, 2026
Coronary atherosclerotic plaque intervention with Tongxinluo capsule (TXL-CAP): a multicenter, randomized, double-blind and placebo-controlled studyMei Ni, Yun Ti, Huai Yu, et al.
Lancet (London, England)|November 9, 2022
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trialYi Li, Zhenyang Liang, Lei Qin, et al.
Cardiovascular Research|November 13, 2025
Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusionYuze Zhang, Qiuting Dong, Xiaohui Bian, et al.
JACC. Asia|May 2, 2026
Treatment Delay in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention in BeijingJinghao Sun, Yixin Ma, Hui Chen, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Circulation|February 26, 2024
Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind TrialYan Yan, Jincheng Guo, Xiao Wang, et al.
Nucleic Acids Research|November 4, 2025
CCCdb: a comprehensive manually curated database for cell-cell communication in human and mouseMingcong Xu, Guorui Zhang, Xuan Wang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 26, 2021
Plaque characteristics in patients with ST-segment elevation myocardial infarction and early spontaneous reperfusionJincheng Guo, Jun Chen, Guozhong Wang, et al.
Current Medical Research and Opinion|March 19, 2019
China STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive patients: a one-year registry (China STATUS III)Yong Huo, Ye Gu, Genshan Ma, et al.
Nucleic Acids Research|October 31, 2021
TcoFBase: a comprehensive database for decoding the regulatory transcription co-factors in human and mouseYuexin Zhang, Chao Song, Yimeng Zhang, et al.
JAMA|March 17, 2015
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trialYaling Han, Jincheng Guo, Yang Zheng, et al.
Signal Transduction and Targeted Therapy|February 24, 2026
Coronary atherosclerotic plaque intervention with Tongxinluo capsule (TXL-CAP): a multicenter, randomized, double-blind and placebo-controlled studyMei Ni, Yun Ti, Huai Yu, et al.
Lancet (London, England)|November 9, 2022
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trialYi Li, Zhenyang Liang, Lei Qin, et al.
Cardiovascular Research|November 13, 2025
Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusionYuze Zhang, Qiuting Dong, Xiaohui Bian, et al.
JACC. Asia|May 2, 2026
Treatment Delay in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention in BeijingJinghao Sun, Yixin Ma, Hui Chen, et al.
Pageof 9